Back
Speaker illustration

Professor Kenji Hamaoka

Kyoto Prefectural University of Medicine, Kyoto (Japan)

Presentations

Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease.

Event: ESC Congress 2018

Topic: Paediatric Cardiology

Session: Special populations

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources
novartis Explore sponsored resources